197 related articles for article (PubMed ID: 36970152)
1. Pretargeted imaging beyond the blood-brain barrier.
Shalgunov V; Lopes van den Broek S; Vang Andersen I; García Vázquez R; Raval NR; Palner M; Mori Y; Schäfer G; Herrmann B; Mikula H; Beschorner N; Nedergaard M; Syvänen S; Barz M; Moos Knudsen G; Battisti UM; Herth MM
RSC Med Chem; 2023 Mar; 14(3):444-453. PubMed ID: 36970152
[TBL] [Abstract][Full Text] [Related]
2. Pretargeted Imaging beyond the Blood-Brain Barrier-Utopia or Feasible?
Lopes van den Broek S; Shalgunov V; García Vázquez R; Beschorner N; Bidesi NSR; Nedergaard M; Knudsen GM; Sehlin D; Syvänen S; Herth MM
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297303
[TBL] [Abstract][Full Text] [Related]
3. Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines.
Bredack C; Edelmann MR; Borroni E; Gobbi LC; Honer M
Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558900
[TBL] [Abstract][Full Text] [Related]
4. Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted
Stéen EJL; Jørgensen JT; Denk C; Battisti UM; Nørregaard K; Edem PE; Bratteby K; Shalgunov V; Wilkovitsch M; Svatunek D; Poulie CBM; Hvass L; Simón M; Wanek T; Rossin R; Robillard M; Kristensen JL; Mikula H; Kjaer A; Herth MM
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):824-833. PubMed ID: 33860205
[TBL] [Abstract][Full Text] [Related]
5. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Structurally Diverse
Adhikari K; Dewulf J; Vangestel C; Van der Veken P; Stroobants S; Elvas F; Augustyns K
ACS Omega; 2023 Oct; 8(41):38252-38262. PubMed ID: 37867688
[No Abstract] [Full Text] [Related]
7. Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System.
Edelmann MR; Bredack C; Belli S; Mohr P; Imhoff MP; Reggiani F; Kusznir EA; Rufer AC; Holt DP; Valentine H; Wong DF; Dannals RF; Honer M; Gobbi LC
Bioconjug Chem; 2023 Oct; 34(10):1882-1893. PubMed ID: 37710950
[TBL] [Abstract][Full Text] [Related]
8. Development of
García-Vázquez R; Jørgensen JT; Bratteby KE; Shalgunov V; Hvass L; Herth MM; Kjær A; Battisti UM
Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215356
[TBL] [Abstract][Full Text] [Related]
9. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
10. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
[TBL] [Abstract][Full Text] [Related]
11. Improved radiosynthesis and preliminary in vivo evaluation of the
Stéen EJL; Jørgensen JT; Petersen IN; Nørregaard K; Lehel S; Shalgunov V; Birke A; Edem PE; L'Estrade ET; Hansen HD; Villadsen J; Erlandsson M; Ohlsson T; Yazdani A; Valliant JF; Kristensen JL; Barz M; Knudsen GM; Kjær A; Herth MM
Bioorg Med Chem Lett; 2019 Apr; 29(8):986-990. PubMed ID: 30795854
[TBL] [Abstract][Full Text] [Related]
12. Pretargeted PET of Osteodestructive Lesions in Dogs.
Maitz CA; Delaney S; Cook BE; Genady AR; Hoerres R; Kuchuk M; Makris G; Valliant JF; Sadeghi S; Lewis JS; Hennkens HM; Bryan JN; Zeglis BM
Mol Pharm; 2022 Sep; 19(9):3153-3162. PubMed ID: 35635337
[TBL] [Abstract][Full Text] [Related]
13.
Stéen EJL; Jørgensen JT; Johann K; Nørregaard K; Sohr B; Svatunek D; Birke A; Shalgunov V; Edem PE; Rossin R; Seidl C; Schmid F; Robillard MS; Kristensen JL; Mikula H; Barz M; Kjær A; Herth MM
ACS Nano; 2020 Jan; 14(1):568-584. PubMed ID: 31820928
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging.
Edem PE; Sinnes JP; Pektor S; Bausbacher N; Rossin R; Yazdani A; Miederer M; Kjær A; Valliant JF; Robillard MS; Rösch F; Herth MM
EJNMMI Res; 2019 May; 9(1):49. PubMed ID: 31140047
[TBL] [Abstract][Full Text] [Related]
15. Development of the First Aliphatic
Battisti UM; Bratteby K; Jørgensen JT; Hvass L; Shalgunov V; Mikula H; Kjær A; Herth MM
J Med Chem; 2021 Oct; 64(20):15297-15312. PubMed ID: 34649424
[TBL] [Abstract][Full Text] [Related]
16. Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue.
Goos JACM; Davydova M; Dilling TR; Cho A; Cornejo MA; Gupta A; Price WS; Puttick S; Whittaker MR; Quinn JF; Davis TP; Lewis JS
Nucl Med Biol; 2020; 84-85():63-72. PubMed ID: 32135473
[TBL] [Abstract][Full Text] [Related]
17. Direct Cu-mediated aromatic
García-Vázquez R; Battisti UM; Jørgensen JT; Shalgunov V; Hvass L; Stares DL; Petersen IN; Crestey F; Löffler A; Svatunek D; Kristensen JL; Mikula H; Kjaer A; Herth MM
Chem Sci; 2021 Sep; 12(35):11668-11675. PubMed ID: 34659701
[TBL] [Abstract][Full Text] [Related]
18. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.
Rondon A; Schmitt S; Briat A; Ty N; Maigne L; Quintana M; Membreno R; Zeglis BM; Navarro-Teulon I; Pouget JP; Chezal JM; Miot-Noirault E; Moreau E; Degoul F
Theranostics; 2019; 9(22):6706-6718. PubMed ID: 31588245
[No Abstract] [Full Text] [Related]
19. Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model.
Bohrmann L; Poulie CBM; Rodríguez-Rodríguez C; Karagiozov S; Saatchi K; Herth MM; Häfeli UO
PLoS One; 2024; 19(4):e0300466. PubMed ID: 38626058
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS
Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
